Appili Therapeutics Inc Class A (TSE:APLI) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Appili Therapeutics Inc. has amended its arrangement agreement with Aditxt, Inc. and increased the deadline for the acquisition of its Class A common shares to August 30, 2024. Additionally, the company has raised its bridge loan amount from C$300,000 to C$400,000 with Bloom Burton & Co. Inc. These financial moves aim to support Appili’s mission in drug development for infectious diseases and medical countermeasures.
For further insights into TSE:APLI stock, check out TipRanks’ Stock Analysis page.
